Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus

• Hirokazu Taniguchi ,

  Contributed equally to this work with: Hirokazu Taniguchi, Shinsuke Nirengi

  Roles Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Writing – original draft

  Affiliations Division of Applied Life Sciences, Graduate School of Life and Environmental Sciences, Kyoto Prefectural University, Kyoto, Japan, Faculty of Agriculture, Ryukoku University, Shiga, Japan

  https://orcid.org/0000-0001-7999-8456

  ⨯
• Shinsuke Nirengi ,

  Contributed equally to this work with: Hirokazu Taniguchi, Shinsuke Nirengi

  Roles Data curation, Investigation, Methodology, Project administration

  Affiliations Division of Preventive Medicine, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan, Department of Physiology and Cell Biology, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America

  ⨯
• Kengo Ishihara,

  Roles Investigation, Methodology, Project administration, Writing – review & editing

  Affiliation Faculty of Agriculture, Ryukoku University, Shiga, Japan

  ⨯
• Naoki Sakane

  Roles Investigation, Methodology, Project administration, Writing – review & editing

  * E-mail: nsakane@gf6.so-net.ne.jp

  Affiliation Division of Preventive Medicine, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan

  ⨯